"Biotime Commits $5 Million to Spinoff Working with Mount Sinai on Big Data-Powered Mhealth Products " - Deanna Pogorelc
In an announcement Tuesday, regenerative medicine company BioTime’s subsidiary LifeMap Sciences said it’s spun off a mobile health company. LifeMap Solutions aims to make health easier to measure and manage by integrating data from mobile devices with other data like genetic profiles, lifestyle data and electronic records in a cloud-based system. It’s doing that by working with researchers at the Icahn School of Medicine at Mount Sinai. Specifically, Eric Schadt, PhD, Director of the Institute for Genomics and Multiscale Biology, Chairman of the Department of Genetics and Genomics Sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai, will lend his expertise as the company’s scientific adviser. Mount Sinai’s focus will be on developing a software engine, while LifeMap will develop the entire technology platform.
-Dr. Eric Schadt, Director of the Institute for Genomics and Multiscale Biology, Chairman of the Department of Genetics and Genomics Sciences and the Jean C. and James W. Crystal Professor of Genomics, Icahn School of Medicine at Mount Sinai
Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind
Dec 04, 2018 View All Press Releases